ZUG, Switzerland & FRANKFURT, Germany--(BUSINESS WIRE)--The BIO-Europe® 2014 international partnering conference will take place in one month on November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt. BIO-Europe is the largest dedicated partnering conference worldwide serving the life science industry.
The 2014 Frankfurt event projects the number of one-to-one partnering meetings to surpass the 2013 all-time record of 17,874 meetings.
The primary draw, and the reason why BIO-Europe is known as a “must-attend” event within the industry, are the one-to-one partnering meetings with high-level executives from across the life science value chain, including pharma and large biotech companies, investors and financiers, and innovative start-ups. These targeted business development meetings enable companies to identify business and licensing opportunities that are essential to their success.
At BIO-Europe, delegates can conduct more meetings at one conference than during the rest of the year. The resulting partnerships bring ground-breaking drugs, therapies and devices to patients around the world.
“The value of partnering is built upon the quality of the companies engaged in the process,” said Roel Bulthuis, VP and Managing Director, MS Ventures. “Our strategy is to fund and support companies that we believe will be future winners in fields relevant to our parent, Merck Serono. We put a lot of energy into finding the right companies or viable opportunities to develop new businesses. There is a huge strategic benefit in being able to meet with a critical mass of investors, early stage biotech, academic researchers, and pre-seed companies at BIO-Europe.”
“The focus of our R&D is on delivering innovative drug candidates to meet the needs of the patients,” said Andreas Busch, Member of the Bayer HealthCare Executive Committee and Head of Global Drug Discovery, Bayer HealthCare. “In that context, complementing our own capabilities with innovative partners from academia and biotech companies plays an important role. We value BIO-Europe because we can meet face-to-face with a large number of companies, which really maximizes our partnering efforts.”
“It’s remarkable how often I hear that a successful partnering deal started with a meeting at BIO-Europe,” said Ben Bonifant, Partner, Triangle Insights Group, LLC.
“The lifeblood of the drug development industry is the ability to uncover new licensing opportunities in the form of new partners,” said Dave Tapolczay, CEO, MRC Technology. “BIO-Europe is about partnering, about uncovering those opportunities.”
At BIO-Europe, one-to-one partnering meetings are facilitated by EBD Group’s highly reputable partneringONE® platform.
Over 3,200 delegates from 1,841 companies representing 56 countries attended BIO-Europe 2013. There were 184 company presentations with close to 3,600 licensing opportunities on offer, and 95 exhibitors at the event.
Registration information is available on the BIO-Europe web site for Europe's largest partnering conference serving the global biotechnology industry.
About BIO-Europe® 2014:
The 20th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.
Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.
Follow BIO-Europe 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BEU14). Or log on to the Life Science Partnering discussion forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.